Vascular gene transfer

Current Opinion in Lipidology

Volumn 8, Issue 2, 1997, Pages 72-76

  Ylä Herttuala, Seppo ^a  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; CYCLIN DEPENDENT KINASE INHIBITOR; FIBROBLAST GROWTH FACTOR; HIRUDIN; NITRIC OXIDE SYNTHASE; PROTEIN P21; REGULATOR PROTEIN; RIBOZYME; THYMIDINE KINASE; TRANSCRIPTION FACTOR; VASCULOTROPIN;

ANGIOGENESIS; ARTERY; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; BLOOD FLOW; CAPILLARY; CARDIOVASCULAR DISEASE; CELL PROLIFERATION; GENE TARGETING; GENE THERAPY; GENE TRANSFER; HEART MUSCLE ISCHEMIA; HOMEOBOX; HUMAN; HUMAN CELL; ISCHEMIA; PRIORITY JOURNAL; RESTENOSIS; REVIEW; SUICIDE GENE; TUMOR SUPPRESSOR GENE; VEIN GRAFT;

ANIMALS; BLOOD VESSELS; CARDIOVASCULAR DISEASES; GENE THERAPY; GENE TRANSFER TECHNIQUES; HUMANS;

EID: 0030953737     PISSN: 09579672     EISSN: None     Source Type: Journal    
DOI: 10.1097/00041433-199704000-00004     Document Type: Review

References (39)

1. Morgan RA, Anderson WF: Human gene therapy. Annu Rev Biochem 1993, 62:191-217.
2. Nabel EG, Nabel GJ: Complex models for the study of gene function in cardiovascular biology. Annu Rev Physiol 1994, 56:741-761.
3. Gibbons GH, Dzau VJ: Molecular therapies for vascular diseases. Science 1996, 272:689-693.
4. Yiä-Herttuala S: Gene therapy for cardiovascular diseases. Ann Med 1996, 28:89-93.
5. Feldman LJ, Isner JM: Gene therapy for the vulnerable plaque. J Am Coll Cardiol 1995, 26:826-835.
6. Flugelman MY: Inhibition of intravascular thrombosis and vascular smooth muscle cell proliferation by gene therapy. Thromb Haemostasis 1995, 74:406-410.
7. Finkel T, Epstein SE: Gene therapy for vascular disease. FASEB J 1995, 9:843-851.
8. Stephan DJ, Yang Z Y, San H, Simari RD, Wheeler CJ, Feigner PL, Gordon D, Nabel GJ, Nabel EG: A new cationic liposome DNA complex enhances the efficiency of arterial gene transfer in vivo. Hum Gene Ther 1996, 7:1803-1812. This paper demonstrates that significant improvements in the transfection efficiency of plasmid/liposome complexes can be achieved with new cationic lipid formulae and expression plasmids.
9. Yee J-K, Miyanohara A, LaPorte P, Bouic K, Burns JC, Friedmann T: A general method for the generation of high-titer, pantropic retroviral vectors: highly efficient infection of primary hepatocytes. Proc Natl Acad Sci U S A 1994, 91:9564-9568.
10. Wilson JM: Adenoviruses as gene-delivery vehicles. N Engl J Med 1996, 334:1185-1187.
11. Bittl JA: Advances in coronary angioplasty. N Engl J Med 1996, 335:1290-1302.
12. Grondin CM, Campeau L, Lespérance J, Enjalbert M, Bourassa MG: Comparison of late changes in internal mammary artery and subvenous vein crafts in two consecutive series of patients 10 years after operation. Circulation 1984, 70:208-212.
13. Simons M, Edelman ER, DeKeyser JL, Langer R, Rosenberg R: Antisense c-myb oligonucleotides inhibit intimai arterial smooth muscle cell accumulation in vivo. Nature 1992, 359:67-73.
14. Morishita R, Gibbons GH, Ellison KE, Nakajima M, von der Leyden H, Zhang L, Yasufumi K, Ogihara T, Dzau VJ: Intimal hyperplasia after vascular injury is inhibited by antisense cdk 2 kinase oligonucleotides. J Clin Invest 1994, 93:1458-1464.
15. Indolfi C, Avvedimento EV, Rapacciuolo A, Di Lorenzo ED, Esposito G, Stabile E, Feliciello A, Mele E, Giuliano P, Condorelli GL, Chiariello M: Inhibition of cellular ras prevents smooth muscle cell proliferation after vascular injury in vivo. Nature Med 1995, 1:541-545.
16. Morishita R, Gibbons GH, Horiuchi M, Ellison KE, Nakajima M, Zhang L, Kaneda Y, Ogihara T, Dzau VJ: A gene therapy strategy using a transcription factor decoy of the E2F binding site Inhibits smooth muscle proliferation in vivo. Proc Natl Acad Sci U S A 1995, 92:5855-5859.
17. Chang MW, Barr E, Lu MM, Barton K, Leiden JM: Adenovirus-mediated over-expression of the cyclin/cyclin-dependent kinase inhibitor, p21 inhibits vascular smooth muscle cell proliferation and neointima formation in the rat carotid artery model of balloon angioplasty. J Clin Invest 1995, 96:2260-2268.
18. Branellec D, Perlman H, Le Roux A, Guo K, Denèfle P, Mahfoudi A, Walsh K: Blockade of smooth muscle cell proliferation by a recombinant adenovirus encoding Gax leads to apoptosis both in vitro and in vivo. The 1996 Meeting on Gene Therapy, Cold Spring Harbor, New York, USA, September 25 29, 1996. Abstr, p. 39.
19. Chang MW, Barr E, Seltzer J, Jiang YQ, Nabel GJ, Nabel EG, Parmacek MS, Leiden JM: Cytostatic gene therapy for vascular proliferative disorders with a constitutively active form of the retinoblastoma gene product. Science 1995, 267:518-522.
20. Ohno T, Gordon D, San H, Pompili VJ, Imperiale MJ, Nabel GJ, Nabel EG: Gene therapy for vascular smooth muscle cell proliferation after arterial injury. Science 1994, 265:781-784.
21. Guzman RJ, Hirschowitz EA, Brody SL, Crystal RG, Epstein SE, Finkel T: In vivo suppression of injury-mediated transfer of the herpes simplex virus thymidine kinase gene. Proc Natl Acad Sci U S A 1994, 91:10732-10736.
22. von der Leyen HE, Gibbons GH, Morishita R, Lewis NP, Zhang L, Nakajima M, Kaneda Y, Cooke JP, Dzau VJ: Gene therapy inhibiting neointimal vascular lesion: in vivo transfer of endothelial cell nitric oxide synthase gene. Proc Natl Acad Sci U S A 1995, 92:1137-1141.
23. Rade JJ, Schulick AH, Virmani R, Dichek DA: Local adenoviral-mediated expression of recombinant hirudin reduces neointima formation after arterial injury. Nature Med 1996, 2:293-298.
24. Takashita S, Tsurumi Y et al.: Gene transfer of naked DNA encoding for three isoforms of vascular endothelial growth factor stimulates collateral development in vivo. Lab Invest 1997 (In press).
25. Nabel EG, Yang Z, Liptay S, San H, Gordon D, Haudenschild CC, Nabel GJ: Recombinant platelet-derived growth factor B gene expression in porcine arteries induces intimal hyperplasia in vivo. J Clin Invest 1993, 91:1822-1829.
26. Nabel EG, Yang Z, Plautz G, Forough R, Zhan X, Haudenschild CC, Maciag T, Nabel GJ: Recombinant fibroblast growth factor-1 promotes intimal hyperplasia and angiogenesis in arteries in vivo. Nature 1993, 362:844-846.
27. Nabel EG, Shum L, Pompili VJ, Yang Z, San H, Shu HB, Liptay S, Gold L, Gordon D, Derynck R, Nabel GJ: Direct transfer of transforming growth factor β1 gene into arteries stimulates fibrocellular hyperplasia. Proc Natl Acad Sci U S A 1993, 90:10759-10763.
28. Ylä-Herttuala S, Luoma J, Viita H, Hiltunen T, Sisto T, Nikkari T: Transfer of 15-lipoxygenase gene into rabbit iliac arteries results in the appearance of oxidation-specific lipid-protein adducts characteristic of oxidized low density lipoprotein. J Clin Invest 1995, 95:2692-2698.
29. Forough R, Hasenstab D, Koyama N, Lea H, Clowes M, Clowes AW: Generating antibodies against secreted proteins using vascular smooth muscle cells transduced with replication-defective retrovirus. BioTechniques 1996, 20:694-701. Authors show that antibodies can be generated against transfected proteins by implantation of transfected cells in arteries.
30. Ylä-Herttuala S, Nikkari T, Hirvonen J, Laaksonen H, Möttönen M, Pesonen E, Raekallio J, Akerblom H: Biochemical composition of coronary arteries in Finnish children. Arteriosclerosis 1986, 6:230-236.
31. Feldman LJ, Steg PG, Zheng LP: Low-efficiency of percutaneous adenovirus-mediated arterial gene transfer in the atherosclerotic rabbit. J Clin Invest 1995, 95:2667-2671. Authors show that transfection efficiency in atherosclerotic arteries is significantly lower than in normal arteries.
32. Landau C, Pirwitz MJ, Willard MA, Gerard RD, Meidell RS, Willard JE: Adenoviral mediated gene transfer to atherosclerotic arteries after balloon angioplasty. Am Heart J 1995, 129:1051-1057.
33. Simari RD, San H, Rekhter M, Ohno T, Gordon D, Nabel GJ, Nabel EG: Regulation of cellular proliferation and intimal formation following balloon injury in atherosclerotic rabbit arteries. J Clin Invest 1996, 98:225-235. The findings indicate that the transfer of thymidine kinase, followed by gancyclovir treatment, inhibits cellular proliferation and limits intimai thickening in balloon-injured atherosclerotic arteries.
34. Newman KD, Dunn PF, Owens JW, Schulick AH, Virmani R, Sukhova G, Libby P, Dichek DA: Adenovirus-mediated gene transfer into normal rabbit arteries results in prolonged vascular cell activation, inflammation, and neointimal hyperplasia. J Clin Invest 1995, 96:2955-2965. Authors report that high-titre adenoviral vectors lead to inflammatory changes, upregulation of adhesion molecules and neointima formation. The results emphasize the importance of the use of optimal viral titre and further development of more inert gene transfer systems.
35. Rome JJ, Shauani V, Flugelman MY, Newman KD, Farb A, Virmani R, Dichek DA: Anatomic barriers influence the distribution of in vivo gene transfer into the arterial wall. Arterioscler Thromb 1994, 14:148-161.
36. Laitinen M, Pakkanen T, Luoma J, Laakso M, Breier G, Risau W, Soma M, Martin JF, Ylä-Herttuala S: Local adventitial VEGF gene transfer reduces neointlma formation in rabbit carotid arteries [Abstract]. Circulation 1996, 94:637.
37. Rios CD, Ooboshi H, Piegors D, Davidson BL, Heistad DD: Adenovirus-mediated gene transfer to normal and atherosclerotic arteries. Arterioscler Thromb Vasc Biol 1995, 15:2241-2245.
38. Giordano FJ, Ping P, McKirnan MD, Nozaki S, DeMaria AN, Dillmann WH, Mathieu-Costello O, Hammond HK: Intracoronary gene transfer of fibroblast growth factor-5 increases blood flow and contractile function in an ischemic region of the heart. Nature Med 1996, 2:534-539.
39. 165 in patient with ischaemic limb. Lancet 1996, 348:370-374. Authors report the first findings from a patient treated with 2000 μg naked VEGF plasmid using a hydrogel-coated angioplasty catheter. Increased number of collateral vessels and increased blood flow were reported in the treated limb.